Cancer Treatment Centers of America


Tasigna® is an oral chemotherapy drug used in the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in some adult patients who have not responded well to other chemotherapy drugs (such as imatinib). Chronic myeloid leukemia (CML) accounts for about 15 percent of all cases of adult leukemia. The majority of CML cases have cells containing the abnormal Philadelphia chromosome. A tyrosine kinase inhibitor, Tasigna® works against cancerous cells by interfering with cell communication and growth.

Our results

our treatment results

View our patient survival rates, along with quality of life, patient experience and quality and patient safety results.

See what CTCA is like

see what ctca is like

Learn about what to expect from your initial consultation through treatment at CTCA.

A team of cancer experts

an expert team just for you

At CTCA, you will be cared for by a team of experienced oncologists and other cancer experts.